chatgpt Blogs

11|06|26

ChatGPT Ads: October 2026 Update and Implications

The advertising landscape in generative AI is moving quickly, and pharma marketers should be paying attention. Since ChatGPT Ads launched in February 2026, OpenAI has rapidly expanded the program to more than 60 countries. While branded prescription drug promotion remains prohibited, recent policy changes have introduced a case-by-case review pathway for select U.S. health categories, including unbranded disease awareness.

11|20|24

The Evolution of Search: How OpenAI’s SearchGPT Enhances ChatGPT’s Capabilities

After nearly a year of stagnant growth, ChatGPT is gaining momentum once again. In this POV, we explore the future of search behavior and emphasize the importance for life science organizations to understand OpenAI’s latest innovation incorporating SearchGPT directly into ChatGPT.

04|11|24

AI-Powered Precision Engagement in Commercial and Medical Functions

AI-powered precision engagement can transform the commercial and medical functions of organizations. Learn how in our latest blog, and one of many POV excerpts from our Innovation as Strategy whitepaper.

04|11|24

Download the 2024 Innovation as Strategy Booklet

Explore our newest series of POVs in the Innovation as Strategy booklet from global innovation leaders and marketing experts as they share a framework, best practices and examples of harnessing innovation as strategy in pharma.

03|02|23

How Will Generative AI Change Pharma? Faruk’s Here to Explain

Faruk Capan, CEO of EVERSANA INTOUCH and Chief Innovation Officer of EVERSANA, has been interviewed by many life-sciences journalists recently about the promise of generative AI like ChatGPT. We round up a few of the recent articles for you here!